A comprehensive meta-analysis in depression and mortality, led by the Department of Psychiatry at the School of Clinical ...

Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have ...

A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...

A clinical LSD formulation shows promise for severe anxiety. Trials reveal meaningful symptom relief and limited side effects ...

Share on Pinterest New research finds that ketamine may be a more effective treatment for severe depression than electroconvulsive therapy. damircudic/Getty Images A new study compares ketamine with ...

The University of Iowa Health Care has introduced a new treatment for depression through its outpatient clinic — Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT therapy. The therapy ...

Nurse-led depression screening in long-term care can boost diagnosis and treatment rates for older adults, according to research presented at GAPNA 2025.

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...

BPL-003 is a novel, nasal spray formulation of mebufotenin benzoate designed to deliver rapid and durable antidepressant effects from a single dose.

For some people with mild depression, natural remedies like herbs and supplements can help relieve symptoms and lift mood.

It stands for Psychiatric Renewal Through Innovative Solutions and Methods. There are a couple of high profile treatments, ...

A one-week, clinician-supported online therapy program significantly reduced anxiety and improved daily functioning for ...